🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Ireland / NCT06588933
Recruiting

TQ-PAL Development and Validation

NCT06588933 · tracked via the Priya Life Science Ireland tracker
Sponsor
Prof Andrew Davies
Phase
Started
2023-09-01
Last updated
2024-09-19

Condition(s) studied

Altered Taste

Investigational drug(s) / intervention(s)

completion of a questionnaire

completion of a questionnaire: completion of a questionnaire by participant

Study summary

Taste problems are common among patients with advanced cancer. These symptoms can affect the pleasure of eating and drinking, reduce dietary intake, cause low mood, and a lower quality of life. There is no validated tool to assess taste disturbances and their impact on patients with advanced cancer. This study will develop and validate a novel assessment tool to assess taste disturbances and their impact on patients with advanced cancer.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 18 years of age Diagnosis of locally advanced or metastatic cancer Referred to palliative care/oncology services Taste problems rated 'moderate' or worse over previous 2-week period Good understanding of English Exclusion Criteria: Cognitive impairment (unable to provide consent / complete questionnaire) Taste problems precedes cancer diagnosis. Head and neck surgery Head and neck radiotherapy Salivary gland disorders (e.g., Sjogren's Syndrome) In the 'Deteriorating' or 'Terminal' Phase of illness

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Our Lady's Hospice & Care Services Dublin Ireland Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06588933 on ClinicalTrials.gov ↗ ← All trials in Ireland